- Home
- ERAS vs TSAT Comparison
ERAS vs TSAT Comparison
Compare ERAS & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- TSAT
- Stock Information
- Founded
- ERAS 2018
- TSAT 1969
- Country
- ERAS United States
- TSAT Canada
- Employees
- ERAS N/A
- TSAT N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- TSAT Metal Fabrications
- Sector
- ERAS Health Care
- TSAT Industrials
- Exchange
- ERAS Nasdaq
- TSAT Nasdaq
- Market Cap
- ERAS 439.7M
- TSAT 394.3M
- IPO Year
- ERAS 2021
- TSAT 1996
- Fundamental
- Price
- ERAS $2.32
- TSAT $30.85
- Analyst Decision
- ERAS Buy
- TSAT
- Analyst Count
- ERAS 6
- TSAT 0
- Target Price
- ERAS $3.83
- TSAT N/A
- AVG Volume (30 Days)
- ERAS 1.7M
- TSAT 129.3K
- Earning Date
- ERAS 11-11-2025
- TSAT 11-13-2025
- Dividend Yield
- ERAS N/A
- TSAT N/A
- EPS Growth
- ERAS N/A
- TSAT N/A
- EPS
- ERAS N/A
- TSAT N/A
- Revenue
- ERAS N/A
- TSAT $358,754,564.00
- Revenue This Year
- ERAS N/A
- TSAT N/A
- Revenue Next Year
- ERAS N/A
- TSAT N/A
- P/E Ratio
- ERAS N/A
- TSAT N/A
- Revenue Growth
- ERAS N/A
- TSAT N/A
- 52 Week Low
- ERAS $1.01
- TSAT $10.11
- 52 Week High
- ERAS $3.31
- TSAT $32.98
- Technical
- Relative Strength Index (RSI)
- ERAS 68.53
- TSAT 76.58
- Support Level
- ERAS $1.78
- TSAT $23.95
- Resistance Level
- ERAS $2.65
- TSAT $26.14
- Average True Range (ATR)
- ERAS 0.20
- TSAT 1.61
- MACD
- ERAS 0.05
- TSAT 0.56
- Stochastic Oscillator
- ERAS 68.34
- TSAT 76.51
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.